{"abstract":"The Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder provides eligible physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives, who are state licensed and registered by the DEA to prescribe controlled substances, an exemption from certain statutory certification requirements related to training, counseling and other ancillary services (i.e., psychosocial services).","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2021/04/28/2021-08961.html","cfr_references":[],"citation":"86 FR 22439","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"This guidance takes effect April 28, 2021.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2021-08961","effective_on":"2021-04-28","end_page":22440,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2021/04/28/2021-08961.xml","html_url":"https://www.federalregister.gov/documents/2021/04/28/2021-08961/practice-guidelines-for-the-administration-of-buprenorphine-for-treating-opioid-use-disorder","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2021-08961?publication_date=2021-04-28","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2021-04-28/2021-08961/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":97679,"last_updated":"2026-04-17 22:15:06 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2021-04-28/pdf/2021-08961.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2021-08961.pdf?1619527536","publication_date":"2021-04-28","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2021/04/28/2021-08961.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":22439,"subtype":null,"title":"Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder","toc_doc":"Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder","toc_subject":null,"topics":[],"type":"Notice","volume":86}